ReviewCureus2026
Superior Migration of the Humeral Head in Chronic Rotator Cuff Disease: A Narrative Review of Pathomechanisms, Diagnosis, and Treatment.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Superior migration of the humeral head (HH) refers to pathological cranial displacement of the HH resulting from chronic rotator cuff (RC) dysfunction and loss of dynamic glenohumeral stabilization. This disturbance is reflected by a reduction of the acromiohumeral interval (AHI), defined as the distance between the inferior border of the acromion and the uppermost part of the HH. Reduced AHI is associated with massive irreparable rotator cuff tears (RCTs), rotator cuff arthropathy (RCA), and inferior surgical outcomes. This narrative review aims to summarize the pathomechanisms, diagnostic value, and treatment implications of superior HH migration in chronic and massive RCTs. Particular emphasis is placed on the clinical relevance of AHI as a marker of disease severity, fatty infiltration, treatment outcomes, and retear risk. While procedures such as partial repair, superior capsular reconstruction (SCR), and lower trapezius transfer (LTT) may improve AHI and shoulder function in selected patients, reverse shoulder arthroplasty (RSA) remains the most reliable option in advanced disease. Although AHI is a simple, inexpensive, and easily accessible marker, it should not serve as a sole criterion for surgical decision-making. Treatment should be tailored to the patient, depending on age, activity demands, and the severity of glenohumeral joint (GHJ) osteoarthritis (OA).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.